CVALFCVALFOTC

Overview Intelligence Charts News Fundamentals Key Metrics Earnings Growth Financials Insiders

Latest News

businesswire.com

Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 25, 2026

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting of shareholders of the Company will be held on Wednesday, March 25, 2026 at 2:00pm Eastern Time in a virtual-only format where shareholders may attend and participate in the meeting via live webcast. The meeting will include a presentation from Covalon's CEO, Brent Ashton, with a Question and Answ.

seekingalpha.com

Covalon Technologies Ltd. (COV:CA) Q1 2026 Earnings Call Transcript

businesswire.com

Covalon Reports on 2026 First Quarter Results and Recent Achievements and Highlights

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company's profile at www.sedarplus.ca. Brent Ashton, Covalon's Chief Executive Officer's commented, “Cova.

businesswire.com

Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company focused on improving patient safety and clinical outcomes, today announced an upcoming Continuing Education webinar to be presented by internationally recognized vascular access expert Dr. Nancy Moureau and hosted by the distinguished Association for Vascular Access (AVA), a leading global authority on vascular access. The webinar will.

businesswire.com

Covalon Announces Conference Call to Discuss First Quarter Fiscal 2026 Results

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q1 Fiscal 2026 results on Wednesday, February 25, 2026, before markets open. A conference call and webcast to discuss the results will be held on Wednesday, February 25, 2026, at 8:30am ET. To view, listen to, and participate in the live webcast, please follow the link below: https://events.q4inc.com/attendee/62026252.

defenseworld.net

Covalon Technologies (OTCMKTS:CVALF) Shares Up 10.5% – What’s Next?

Shares of Covalon Technologies Ltd. (OTCMKTS:CVALF - Get Free Report) shot up 10.5% on Friday. The company traded as high as $1.37 and last traded at $1.37. 51,712 shares changed hands during mid-day trading, an increase of 512% from the average session volume of 8,443 shares. The stock had previously closed at $1.24. Covalon

seekingalpha.com

Covalon Technologies Ltd. (COV:CA) Q4 2025 Earnings Call Transcript

businesswire.com

Covalon Reports Highest Revenue Quarter of Fiscal Year 2025, Delivers Third Consecutive Year of Revenue Growth

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 fourth quarter and full 2025 fiscal year results for the period ended September 30, 2025, along with a number of important recent achievements and highlights. Brent Ashton, Covalon's Chief Executive Officer, commented, “Covalon has made significant progress as a company to close out our fiscal year 2025.

businesswire.com

Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year end Fiscal 2025 financial results on Thursday, December 11, 2025, before markets open. A conference call and webcast to discuss the financial results will be held on Thursday, December 11, 2025, at 8:30am ET. To view, listen to, and participate in the live webcast, please follow the link below: https://eve.

businesswire.com

Covalon Technologies Ltd. Announces Payment of First Ever Dividend, Marking a Milestone in Financial Strength

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the payment on November 18, 2025 of its first ever dividend – a special cash dividend of C$0.15 per common share – reflecting the Company's strong financial performance and continued success in accelerating the adoption of its unique, patented, life-saving and life-improving medical technologies. This special dividend.

businesswire.com

Covalon Declares First Ever Special Cash Dividend

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that its Board of Directors has declared a special cash dividend (the “Special Dividend”) in the aggregate amount of $4,112,711.55 CAD, being $0.15 CAD per common share of the Company to be paid on November 18, 2025 to shareholders of record at the close of business on November 4, 2025 (the “Record Date”). The Special.

businesswire.com

Covalon to Participate in the Planet MicroCap Showcase: TORONTO on October 22, 2025

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company improving lives through innovative wound care, vascular access, and surgical solutions, is pleased to announce its participation at the Planet MicroCap Showcase: TORONTO 2025, in partnership with MicroCapClub. Brent Ashton, Covalon's Chief Executive Officer, will participate in a fireside chat with Mathieu Martin, Portfolio Manager at.

businesswire.com

Empowering Nurses with Innovation: Covalon Showcases Patient Safety Solutions to Tackle Preventable Complications at ANCC National Magnet & Pathway Conference

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company focused on improving patient safety and clinical outcomes, today announced its upcoming participation in the 2025 American Nurses Credentialing Center (ANCC) National Magnet® & Pathway to Excellence Conference™, taking place October 8–10, 2025 in Atlanta, Georgia. Magnet® designation is the highest international recognition a hospi.

businesswire.com

Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its participation in the Association of Pediatric Hematology/Oncology Nurses (APHON) 49th Annual Conference, September 25–27, 2025 in Providence, Rhode Island. The annual conference, attended by more than 800 nurse leaders from across the United States and around the world, is recognized as the premier educational experience.

businesswire.com

Covalon Announces Departure of Executive Chair and the Appointment of its Largest Shareholder as New Chair

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that Mr. Abe Schwartz has been elected Chair of the Board of the Company. Mr. Schwartz succeeds Mr. Amir Boloor, who has decided to step down as a director and Executive Chair of Covalon with effect today. Mr. Schwartz, a member of the Covalon Board since 2008, has previously served as Covalon Board Chair from 2012 unt.

businesswire.com

Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon's Presence at the Association for Vascular Access 2025 Annual Meeting

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, announced its participation at the Association for Vascular Access (AVA) Annual Scientific Meeting in Orlando, Florida, from September 18–21, 2025. Attendees will have the opportunity to explore Covalon's innovative vascular access and infection prevention solutions and learn why leading hospitals in the United States and beyond are i.

businesswire.com

Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs)

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the publication of results from a peer-reviewed clinical study investigating the use of Covalon's VALGuard® Vascular Access Line Guard in the Journal of the Association for Vascular Access (JAVA). Conducted at the Children's Hospital at Montefiore, a nationally ranked U.S. pediatric hospital, the study, titled “Evaluat.

seekingalpha.com

Covalon Technologies Ltd. (CVALF) Q3 2025 Earnings Call Transcript

Covalon Technologies Ltd. (OTCQX:CVALF) Q3 2025 Earnings Conference Call August 21, 2025 8:30 AM ET Company Participants Brent Ashton - CEO & Director Saleha Assadzada - Corporate Participant Operator Good morning, ladies and gentlemen, and welcome to the Covalon's Q3 Fiscal 2025 Conference Call and Webcast.

businesswire.com

Covalon Reports Strong Sequential Quarter on Quarter and Trailing Twelve Months Performance

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 third quarter results for the period ended June 30, 2025, along with a number of important recent achievements and highlights. Brent Ashton, Covalon's Chief Executive Officer, reported, “The Covalon team has made numerous advancements on our strategic priorities in the past few months. This solid progre.

businesswire.com

Covalon Technologies Ltd. Achieves DTC Eligibility in the United States

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce that its common shares are now eligible for electronic clearing and settlement in the United States through The Depository Trust Company (“DTC”). DTC eligibility simplifies the trading process for Covalon shares on the U.S. OTCQX Market under the symbol CVALF by eliminating manual delays and higher transaction c.

Loading news...

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance